Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium -- Ignore unavailable to you. Want to Upgrade?

To: Craig K who wrote (13376)	8/4/1999 10:17:00 AM
From: jeffrey rainey	Read Replies (1) \| Respond to of 108040

LAJD coming off it's bottom, big news means good revenues for this company...FULLY reporting and more deals in the works! La Jolla Diagnostics' Subsidiary, DiagnosTech, Received Standing Order from the Philippines LA JOLLA, Calif.--(BW HealthWire)--Aug. 4, 1999--La Jolla Diagnostics Inc. (OTCBB:LAJD - news) announced today that its subsidiary, DiagnosTech Inc., has received a standing order from its Philippine distributor to supply its rapid diagnostic tests for TB and HIV on an on going basis. This order follows the Philippine Bureau of Food and Drugs recent approval of DiagnosTech's products in the Philippines. Bruce Whitfield, the company's vice president of marketing, upon returning from the Philippines commented, ''The market is receptive to our products and the need is extraordinary. With a population of over 70 million people, the Philippines represents an enormous market for us. ''TB is a major health problem in most of the world, and is especially prevalent throughout Asia. HIV is also a large and growing problem in Asia.'' DiagnosTech manufactures and markets state of the art rapid medical diagnostic tests, including tests for TB, HIV, Hepatitis B, pregnancy and H. pylori. The company believes that its proprietary and patent-pending TB test is the only rapid test proven to determine the presence or absence of active TB disease. The World Health Organization (WHO) estimates that 1 billion TB tests will be performed in the year 2000. Contact: La Jolla Diagnostics Inc. Don Brucker, 800/454-6790, Fax 619/454-7851 lajd.com lajd96@aol.com